Competition to get fiercer for Olmetec generic market

Korean companies are poised to step up their marketing in domestic Olmetec generics market, which is forecast to become more competitive than even early this year, according to industry source.

The Korea Food and Drug Administration will reportedly approve about 130 Olmetec generics next month until their minor GMP modifications are to be met.

30-odd manufacturers are expected to produce ...